Collette Palmisano, ARNP

Collette Palmisano practices at Sabal Palms Health & Rehabilitation in Largo, Florida.

Collette Palmisano's NPI, 1528174216, was assigned on August 22, 2006. Collette Palmisano holds Florida license APRN3135202.

Collette Palmisano's primary practice is Sabal Palms Health & Rehabilitation, at 499 Alternate Keene Rd Ne, Largo, FL 33771 in Pinellas County. The practice phone is (727) 586-4211.

Collette Palmisano's primary practice is Sabal Palms Health & Rehabilitation in Largo, Florida. The medical group on file is CareConnectMD. Dmand AI also links Collette Palmisano to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Collette Palmisano practices, 4 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Collette Palmisano's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Collette Palmisano is licensed in Florida.

Dmand AI lists arthritis, benign or precancerous skin growths, chronic diabetes, chronic kidney disease, chronic obstructive pulmonary disease (COPD), epilepsy, high cholesterol and mobility impairment among the conditions Collette Palmisano treats.

CMS data shows 1,588 Medicare services from Collette Palmisano across 5 procedure codes in 2024, for 382 Medicare patients. Medicare paid $86,165 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 382 Medicare patients who saw Collette Palmisano in 2024. The largest group is 85 and over, with 156 patients. 75% of them have arthritis, and 75% have chronic kidney disease. 62% are also on Medicaid. Their average risk score is 3.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Collette Palmisano's median patient age at 85, with 63% women.

In 2024, Collette Palmisano wrote 181 Medicare Part D claims for 91 patients. 74% of them were for generic drugs. CMS names the drug for 117 of them, across 5 drugs with 11 or more claims each, at $37,109 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Collette Palmisano for performance year 2024, reported individually.

CMS Open Payments shows 3 general payments to Collette Palmisano from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Smith & Nephew, Inc. paid the most, $56.